Kathleen Beusterien

4.2k total citations
101 papers, 3.2k citations indexed

About

Kathleen Beusterien is a scholar working on Psychiatry and Mental health, Oncology and Economics and Econometrics. According to data from OpenAlex, Kathleen Beusterien has authored 101 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 16 papers in Oncology and 16 papers in Economics and Econometrics. Recurrent topics in Kathleen Beusterien's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Statistical Methods in Clinical Trials (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Kathleen Beusterien is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Statistical Methods in Clinical Trials (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Kathleen Beusterien collaborates with scholars based in United States, United Kingdom and Germany. Kathleen Beusterien's co-authors include John E. Ware, Emuella Flood, Henrik Balle Boysen, Anette Bygum, Emel Aygören‐Pürsün, Teresa Caballero, E. Hautamaki, Zlatko Sisic, Suzanne Wait and Philip Asherson and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kathleen Beusterien

89 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen Beusterien United States 31 508 450 445 423 363 101 3.2k
Moshe Fridman United States 32 515 1.0× 278 0.6× 178 0.4× 243 0.6× 674 1.9× 132 3.8k
Henry J. Henk United States 28 363 0.7× 267 0.6× 223 0.5× 258 0.6× 361 1.0× 84 2.5k
Heiner Raspe Germany 31 632 1.2× 138 0.3× 530 1.2× 326 0.8× 213 0.6× 208 4.0k
Anne M. Rentz United States 38 443 0.9× 205 0.5× 483 1.1× 323 0.8× 116 0.3× 74 4.3k
Linda Abetz United States 30 867 1.7× 271 0.6× 713 1.6× 177 0.4× 113 0.3× 66 4.6k
Jeremy Kirk United Kingdom 32 469 0.9× 194 0.4× 421 0.9× 403 1.0× 93 0.3× 120 5.4k
Elizabeth Molsen United States 8 262 0.5× 101 0.2× 279 0.6× 446 1.1× 220 0.6× 8 2.6k
Henrik Frederiksen Denmark 36 230 0.5× 838 1.9× 200 0.4× 97 0.2× 463 1.3× 193 4.3k
Alan L. Shields United States 23 170 0.3× 159 0.4× 494 1.1× 176 0.4× 249 0.7× 72 2.5k
Julio López‐Bastida Spain 31 278 0.5× 210 0.5× 249 0.6× 611 1.4× 174 0.5× 76 2.5k

Countries citing papers authored by Kathleen Beusterien

Since Specialization
Citations

This map shows the geographic impact of Kathleen Beusterien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Beusterien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Beusterien more than expected).

Fields of papers citing papers by Kathleen Beusterien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Beusterien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Beusterien. The network helps show where Kathleen Beusterien may publish in the future.

Co-authorship network of co-authors of Kathleen Beusterien

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Beusterien. A scholar is included among the top collaborators of Kathleen Beusterien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Beusterien. Kathleen Beusterien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coleman, Robert L., et al.. (2025). Oncologist perceptions of “cure” and long-term management in advanced ovarian cancer in the United States: results from a cross-sectional survey. International Journal of Gynecological Cancer. 35(7). 101919–101919.
2.
Hauber, Brett, Kathleen Beusterien, Amy Law, et al.. (2024). A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States. Human Vaccines & Immunotherapeutics. 20(1). 2358566–2358566. 8 indexed citations
3.
Beusterien, Kathleen, et al.. (2024). A Novel Approach to Computing Preference Estimates for Different Treatment Pathways: An Application in Oncology. Patient. 17(4). 397–406. 2 indexed citations
4.
Vietri, Jeffrey, et al.. (2024). Preferences for a Clostridioides difficile vaccine among adults in the United States. Vaccine. 42(24). 126261–126261.
5.
Beusterien, Kathleen, et al.. (2023). Patient Preferences for Adjuvant Treatment in Muscle-Invasive Urothelial Carcinoma: A Multi-Country Discrete Choice Experiment. Patient Preference and Adherence. Volume 17. 2237–2248. 3 indexed citations
6.
Collin-Histed, Tanya, Kathleen Beusterien, Deborah Elstein, et al.. (2023). A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative. Orphanet Journal of Rare Diseases. 18(1). 195–195. 6 indexed citations
7.
Cambron‐Mellott, M. Janelle, Jiat Ling Poon, Qianqian Wang, et al.. (2022). Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3601–3615.
8.
Tolaney, Sara M., et al.. (2022). Benefit-Risk Trade-Offs in Treatment Choice in Advanced HER2 Negative Breast Cancer: Patient and Oncologist Perspectives. Future Oncology. 18(16). 1927–1941. 7 indexed citations
9.
10.
Cambron‐Mellott, M. Janelle, et al.. (2021). Patient and neurologist preferences in the UK for relapsing–remitting multiple sclerosis treatments: findings from a discrete choice experiment. Current Medical Research and Opinion. 37(9). 1589–1598. 6 indexed citations
11.
Stone, Rebecca L., et al.. (2021). Patients’ and oncologists’ preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer. Future Oncology. 18(4). 491–503. 4 indexed citations
12.
Cambron‐Mellott, M. Janelle, et al.. (2021). Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment. Patient Preference and Adherence. Volume 15. 1061–1073. 5 indexed citations
13.
Cambron‐Mellott, M. Janelle, et al.. (2021). Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment. Patient Preference and Adherence. Volume 15. 1515–1527. 10 indexed citations
14.
Beusterien, Kathleen, et al.. (2021). Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment. Patient Preference and Adherence. Volume 15. 611–623. 12 indexed citations
15.
16.
Chiba, Tetsuhiro, Atsushi Hiraoka, Shigeru Mikami, et al.. (2019). <p>Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments</p>. Patient Preference and Adherence. Volume 13. 637–647. 9 indexed citations
17.
Beusterien, Kathleen, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 361–361. 19 indexed citations
18.
Hashim, Hashim, et al.. (2015). Patient preferences for treating refractory overactive bladder in the UK. International Urology and Nephrology. 47(10). 1619–1627. 27 indexed citations
19.
Winblad, Bengt, Ariane K. Kawata, Kathleen Beusterien, et al.. (2007). Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease. International Journal of Geriatric Psychiatry. 22(5). 485–491. 86 indexed citations
20.
Leidy, Nancy Kline, et al.. (2006). Integrating the Patient's Perspective into Device Evaluation Trials. Value in Health. 9(6). 394–401. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moshe Fridman Breakdown of academic impact, for papers by Henry J. Henk Breakdown of academic impact, for papers by Heiner Raspe Breakdown of academic impact, for papers by Anne M. Rentz Breakdown of academic impact, for papers by Linda Abetz Breakdown of academic impact, for papers by Jeremy Kirk Breakdown of academic impact, for papers by Elizabeth Molsen Breakdown of academic impact, for papers by Henrik Frederiksen Breakdown of academic impact, for papers by Alan L. Shields Breakdown of academic impact, for papers by Julio López‐Bastida
Rankless by CCL
2026